TIB by Elizabeth Nance (UW)

Date: 

Tuesday, April 18, 2017, 11:45am to 1:00pm

Location: 

Haller Hall, Geo Museum 102, Harvard

Title:  Nano-based probes of neuroinflammation: implications for therapeutic intervention in the brain

Abstract:

Currently, the means to gather real-time molcular information from the diseased human brain is limited, and high-throughput platforms that can assay neurological disease severity representative of the in vivo environment are still lacking. In addition, for the treatment of brain diseases, penetration, movement, and cellular interaction of a therapeutic within the brain is critical to the success of the therapeutic. Nanotechnology, which consists of small, high-tailorable platforms, can provide a modality to survey a disease environment, as well as a vehicle for site-specific, controlled , and sustained-release of therapeutics to the central nervous system (CNS). Our research combines nanotechnology and neuroscience tools with preclinical models to understand transport limitations at the macro- and micro-scale in the brain. One aim of work is to focus on developing  a high throughput, quantitative, real-time method of imaging cell and nanoparticle behavior within the neonatal or perinatal brain in the presence of disease. When engineered nanoparticles leverage transport behavior in the brain, these platforms can be targeted to regions of the rain that contain diseased cells, as well as to specific cell types within those regions. A second aim of our work is to use systems-level thinking to characterize how common disease hallmarks, such as inflammation, impaired fluid flow, and excitotoxicity, play a role in the ability to diagnose and treat neurodevelopmental diseases. In this seminar, we will focus on inflammation-mediated brain disease in the developing brain, including cerebral palsy and neonatal stroke, and the use of nanotechnology as a probe of neuroinflammation. Our long-term goal is to utilize a system-analysis approach in patients to give real-time, quantitative information about the brain that can take advantage of the presence of disease hallmarks to improve diagnosis and direct our therapeutic strategies.